424B4424B4
Jul 15, 2026Final prospectus0001104659-26-083680
All companies
Trade Aeon Biopharma Inc424B4Jul 15, 2026
AE
Aeon Biopharma Inc
AEONPublic
PublicUnited States(NYSE)Best valuation $10.57M1 market
Public listing
Listed· NYSE· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, sec-edgar, nasdaq
IPO Calendar · NYSEIPO
AEONPrice
$0.2119
24h
+7.35%
Valuation
$10.57M
24h volume
$8.64M
Type
IPO
Trade Aeon Biopharma IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Aeon Biopharma Inc IPO public float & lock-up
Public float and locked shares extracted from Aeon Biopharma Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
69M
Public float
—
Locked
—
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001837607.
Revenue
—
Net income
-$39.22M
Gross margin
—
Cash
$3.01M
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$12.8M | $72.99M | — | -$48.43M | -$1.94M |
| Net income | -$39.22M | $42.01M | — | -$52.56M | $8.2M |
| R&D expense | $4.09M | $14.18M | — | $34.75M | — |
| Cash & equivalents | $3.01M | $13K | $5.16M | $9.75M | $497.41K |
| Total assets | $5.56M | $3.14M | $6.85M | $10.78M | $276.95M |
| Total liabilities | $60.59M | $31.71M | $159.89M | $143.24M | $17.88M |
| Shareholders' equity | — | — | -$153.04M | -$287.5M | -$16.93M |
SEC IPO filings
Final prospectusEDGAR filings resolved from AEON / CIK 0001837607.
Jul 13, 2026Effective9999999995-26-002285
S-1/AS-1/A
Jul 9, 2026Amended0001104659-26-082167
S-1S-1
Jul 8, 2026Filed0001104659-26-081860
May 29, 2026Confidential draft0001104659-26-068203
424B3424B3
Feb 18, 2026Final prospectus0001104659-26-017037
Feb 17, 2026Effective9999999995-26-000613
CORRESPfilename1.htm
Feb 12, 2026SEC correspondence0001104659-26-014404
UPLOADfilename1.pdf
Feb 12, 2026SEC correspondence0000000000-26-001525
UPLOADfilename1.pdf
Feb 28, 2025SEC correspondence0000000000-25-002324
424B3424B3
Nov 13, 2024Final prospectus0001837607-24-000094
Aug 21, 2024Effective9999999995-24-002598
Aeon Biopharma Inc IPO — frequently asked questions
- When did Aeon Biopharma Inc go public?
- Aeon Biopharma Inc has already gone public and now trades publicly on NYSE under the ticker AEON.
- Can I buy Aeon Biopharma Inc stock?
- Yes — Aeon Biopharma Inc is publicly traded on NYSE as AEON. You can follow its live price, valuation and post-IPO performance above.
- What is Aeon Biopharma Inc's valuation?
- Aeon Biopharma Inc's most recent valuation tracked here is $10.57M, derived from live market prices.